See more : TomTom N.V. (TOM2.AS) Income Statement Analysis – Financial Results
Complete financial analysis of Equasens Société anonyme (0R9T.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Equasens Société anonyme, a leading company in the Medical – Equipment & Services industry within the Healthcare sector.
- AMETEK, Inc. (AME) Income Statement Analysis – Financial Results
- China Leadshine Technology Co., Ltd. (002979.SZ) Income Statement Analysis – Financial Results
- Grupo Supervielle S.A. (SUPV.BA) Income Statement Analysis – Financial Results
- Asia Plastic Recycling Holding Limited (1337.TW) Income Statement Analysis – Financial Results
- Pioneer Merger Corp. (PACXU) Income Statement Analysis – Financial Results
Equasens Société anonyme (0R9T.L)
About Equasens Société anonyme
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 219.79M | 214.08M | 193.07M | 171.75M | 158.57M | 148.48M | 129.67M | 128.38M | 113.48M | 114.56M | 113.41M | 108.72M | 97.06M | 91.55M | 81.62M | 74.80M | 70.95M | 67.36M | 63.62M | 60.67M |
| Cost of Revenue | 149.91M | 68.55M | 59.25M | 52.45M | 50.32M | 101.26M | 88.10M | 90.73M | 80.21M | 84.35M | 85.70M | 44.16M | 27.84M | 25.48M | 31.80M | 17.67M | 0.00 | 27.21M | 25.45M | 26.23M |
| Gross Profit | 69.88M | 145.52M | 133.82M | 119.31M | 108.25M | 47.22M | 41.57M | 37.65M | 33.27M | 30.21M | 27.70M | 64.57M | 69.22M | 66.07M | 49.82M | 57.13M | 70.95M | 40.15M | 38.17M | 34.44M |
| Gross Profit Ratio | 31.79% | 67.98% | 69.31% | 69.46% | 68.26% | 31.80% | 32.06% | 29.33% | 29.32% | 26.37% | 24.43% | 59.39% | 71.32% | 72.17% | 61.04% | 76.38% | 100.00% | 59.61% | 60.00% | 56.77% |
| Research & Development | 0.00 | 6.55M | 0.00 | 3.47M | 0.00 | 0.00 | 648.00K | 3.72M | 3.67M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.15M | 31.43M | 28.56M | 27.75M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 427.00K | 71.00K | 0.00 | 0.00 | 8.00K | 0.00 | -648.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.96M | 46.15M | 31.43M | 28.56M | 27.75M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 14.24M | 89.76M | 83.55M | 72.66M | 67.40M | -3.10M | -3.03M | -2.80M | -2.36M | 0.00 | 43.53M | 44.42M | 39.48M | 3.11M | 4.15M | 32.52M | 31.14M | 29.14M | 28.57M | 26.00M |
| Operating Expenses | 14.67M | 89.76M | 83.55M | 72.66M | 67.40M | 8.31M | 7.72M | 6.22M | 4.99M | 4.83M | 4.38M | 44.42M | 51.44M | 49.26M | 35.58M | 61.07M | 58.89M | 29.14M | 28.57M | 26.00M |
| Cost & Expenses | 164.58M | 158.31M | 142.80M | 125.10M | 117.72M | 109.57M | 95.82M | 96.95M | 85.20M | 89.18M | 90.08M | 88.58M | 79.28M | 74.74M | 67.38M | 78.74M | 58.89M | 56.35M | 54.02M | 52.23M |
| Interest Income | 3.87M | 1.61M | 921.00K | 1.34M | 1.93M | 853.00K | 1.13M | 981.00K | 989.00K | 979.00K | 1.01M | 67.00K | 3.00K | 640.00K | 860.00K | 876.00K | 634.00K | 440.00K | 18.00K | 26.00K |
| Interest Expense | 669.00K | 679.00K | 589.00K | 571.00K | 414.00K | 294.00K | 218.00K | 110.00K | 144.00K | 159.00K | 150.00K | 71.00K | 117.00K | 168.00K | 348.00K | 0.00 | 1.22M | 439.00K | 127.00K | 177.00K |
| Depreciation & Amortization | 13.58M | 12.30M | 11.33M | 9.02M | 7.44M | 5.21M | 4.24M | 3.47M | 2.96M | 2.52M | 2.82M | 2.44M | 1.76M | 1.79M | 1.84M | 1.68M | 899.00K | 782.00K | 1.65M | 858.00K |
| EBITDA | 71.30M | 67.36M | 63.77M | 55.82M | 50.20M | 44.22M | 39.55M | 34.85M | 31.17M | 28.00M | 27.14M | 22.58M | 20.66M | 18.80M | 16.81M | -2.26M | -10.42M | 12.28M | 11.27M | 9.32M |
| EBITDA Ratio | 32.44% | 32.24% | 33.33% | 32.42% | 31.97% | 29.78% | 29.69% | 27.15% | 27.47% | 24.44% | 22.88% | 20.77% | 20.34% | 20.84% | 20.69% | -3.02% | -14.68% | 18.23% | 17.71% | 15.37% |
| Operating Income | 55.21M | 55.21M | 50.27M | 46.13M | 40.85M | 38.99M | 34.26M | 31.39M | 28.21M | 25.48M | 23.12M | 20.14M | 17.99M | 17.30M | 15.04M | -3.94M | -11.32M | 11.50M | 9.62M | 8.47M |
| Operating Income Ratio | 25.12% | 25.79% | 26.03% | 26.86% | 25.76% | 26.26% | 26.42% | 24.45% | 24.86% | 22.25% | 20.39% | 18.53% | 18.53% | 18.89% | 18.43% | -5.26% | -15.95% | 17.07% | 15.12% | 13.95% |
| Total Other Income/Expenses | 2.20M | -832.00K | 1.51M | -189.00K | 1.43M | 774.00K | 678.00K | 1.03M | 1.06M | 851.00K | 1.22M | 1.13M | 729.00K | 114.00K | 455.00K | 17.39M | -25.00M | -22.82M | 623.00K | 401.00K |
| Income Before Tax | 57.41M | 54.38M | 51.85M | 45.95M | 42.34M | 39.76M | 34.98M | 32.41M | 29.27M | 26.36M | 24.34M | 21.27M | 18.52M | 16.93M | 14.69M | 13.46M | -12.94M | 11.60M | 10.22M | 8.84M |
| Income Before Tax Ratio | 26.12% | 25.40% | 26.86% | 26.75% | 26.70% | 26.78% | 26.98% | 25.25% | 25.79% | 23.01% | 21.46% | 19.56% | 19.08% | 18.49% | 18.00% | 17.99% | -18.24% | 17.22% | 16.07% | 14.57% |
| Income Tax Expense | 9.70M | 6.18M | 10.62M | 13.40M | 13.31M | 12.72M | 10.69M | 10.95M | 10.27M | 9.39M | 8.51M | 7.37M | 6.41M | 5.89M | 5.08M | 4.57M | -4.39M | 4.08M | 3.59M | 3.14M |
| Net Income | 47.05M | 46.38M | 39.12M | 30.71M | 28.40M | 25.43M | 23.14M | 20.57M | 18.79M | 17.01M | 15.83M | 13.52M | 11.75M | 11.04M | 9.61M | 9.10M | -8.55M | 7.30M | 5.68M | 5.01M |
| Net Income Ratio | 21.41% | 21.66% | 20.26% | 17.88% | 17.91% | 17.13% | 17.84% | 16.02% | 16.56% | 14.85% | 13.95% | 12.43% | 12.11% | 12.06% | 11.77% | 12.17% | -12.06% | 10.84% | 8.92% | 8.26% |
| EPS | 3.13 | 3.08 | 2.60 | 2.04 | 1.89 | 1.70 | 1.55 | 1.37 | 1.25 | 1.14 | 1.04 | 0.89 | 0.78 | 0.73 | 0.64 | 0.60 | -0.57 | 0.49 | 0.38 | 0.33 |
| EPS Diluted | 3.10 | 3.05 | 2.58 | 2.04 | 1.89 | 1.68 | 1.53 | 1.36 | 1.24 | 1.12 | 1.04 | 0.89 | 0.77 | 0.73 | 0.63 | 0.60 | -0.56 | 0.48 | 0.37 | 0.33 |
| Weighted Avg Shares Out | 15.03M | 15.03M | 15.02M | 15.07M | 15.03M | 14.97M | 15.16M | 15.12M | 15.15M | 15.17M | 15.17M | 15.17M | 15.06M | 15.04M | 14.98M | 15.17M | 15.00M | 15.00M | 14.99M | 14.99M |
| Weighted Avg Shares Out (Dil) | 15.17M | 15.17M | 15.17M | 15.07M | 15.03M | 15.17M | 15.17M | 15.17M | 15.17M | 15.19M | 15.17M | 15.17M | 15.17M | 15.18M | 15.17M | 15.17M | 15.18M | 15.17M | 15.17M | 15.17M |
Source: https://incomestatements.info
Category: Stock Reports